Continual supplementation with n-3 fatty acids does not modify plasma lipid profile in spinal cord injury patients

A prospective study during a diet modification. To observe the evolution of the plasma lipid profile in a group of spinal cord injury (SCI) patients given a supplement of a mixture of docosahexanoic acid (DHA) and eicosapentaenoic acid (EPA). Department of Physiological Sciences II, Medical School o...

Full description

Saved in:
Bibliographic Details
Published in:Spinal cord 2005-09, Vol.43 (9), p.527-530
Main Authors: JAVIERRE, C, VIDAL, J, SEGURA, R, MEDINA, J, GARRIDO, E
Format: Article
Language:English
Subjects:
Administration, Oral
Biological and medical sciences
Cerebrospinal fluid. Meninges. Spinal cord
Diet Therapy - methods
Dietary Supplements
Fatty Acids, Omega-3 - administration & dosage
Humans
Injuries of the nervous system and the skull. Diseases due to physical agents
Lipids - blood
Male
Medical sciences
Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
Nervous system (semeiology, syndromes)
Neurology
Prospective Studies
Spinal Cord Injuries - blood
Spinal Cord Injuries - drug therapy
Traumas. Diseases due to physical agents
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A prospective study during a diet modification. To observe the evolution of the plasma lipid profile in a group of spinal cord injury (SCI) patients given a supplement of a mixture of docosahexanoic acid (DHA) and eicosapentaenoic acid (EPA). Department of Physiological Sciences II, Medical School of the University of Barcelona and Guttmann Institut of Badalona, Barcelona, Spain. A total of 19 adult males with SCI, 17 with paraplegia and two with tetraplegia, were given a daily supplement of 1.5 g of DHA and 0.75 g of EPA for 6 months. Determination of plasma values of DHA, EPA, total cholesterol, HDL-c, LDL-c, VLDL-c, triglycerides, and glucose was performed before supplementation and at 3 and 6 months of supplementation. A statistically significant increase in the plasma concentration of EPA (F=30.556, P
ISSN:1362-4393
1476-5624
DOI:10.1038/sj.sc.3101762